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Unit of analysis issues in
laboratory-based research
Abstract Many studies in the biomedical research literature report analyses that fail to recognise important data
dependencies from multilevel or complex experimental designs. Statistical inferences resulting from such analyses
are unlikely to be valid and are often potentially highly misleading. Failure to recognise this as a problem is often
referred to in the statistical literature as a unit of analysis (UoA) issue. Here, by analysing two example datasets in a
simulation study, we demonstrate the impact of UoA issues on study efficiency and estimation bias, and highlight
where errors in analysis can occur. We also provide code (written in R) as a resource to help researchers undertake
their own statistical analyses.
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Introduction
Defining the experimental unit is a key step in
the design of any experiment. The experimental
unit is the smallest object or material that can be
randomly and independently assigned to a par-
ticular treatment or intervention in an experi-
ment (Mead et al., 2012). The experimental unit
(e.g. a tissue sample, individual animal or study
participant) is the object a scientist wants to
make inferences about in the wider population,
based on a sample in the experiment. In the sim-
plest possible experimental setting where each
experimental unit provides a single outcome or
observation, and only in this setting, the experi-
mental unit is the same as both the unit of
observation (i.e the unit described by the
observed outcomes) and the unit of analysis
(UoA) (i.e. that which is analysed). In general this
will not always be the case, so care must be
taken, both when planning and reporting
research, to clearly define the experimental unit,
and what data are being analysed and how
these relate to the aims of the study.
In laboratory based research in the biomedi-
cal sciences it is almost always the case that mul-
tiple observations or measurements are made
for each experimental unit. These multiple
observations, which could be simple replicate
measurements from a single sample or observa-
tions from multiple sub-samples taken from a
single sample, allow the variability of the mea-
sure and the stability of the experimental setting
to be assessed. They improve the overall statisti-
cal power of a research study. However, multiple
or repeat observations taken from the same
experimental unit tend to be more similar than
observations taken from different experimental
units, irrespective of the treatments applied or
when no treatments are applied. Therefore data
within experimental units are likely to be depen-
dent (correlated), whereas data from different
experimental units are generally assumed to be
independent, all other things being equal (i.e
after removing the direct and indirect effects of
the experimental interventions and setting).
The majority of widely reported statistical
methods (e.g. t-tests, analyses of variance, gen-
eralized linear models, chi-squared tests) assume
independence between all observations in an
analysis, possibly after conditioning on other
observed data variables. If the UoA is the same
as the experimental unit (i.e. a single observa-
tion or summary measure is available for each
unit) then the independence assumption is likely
to be met. However, many studies reported in
the biomedical research literature using multi-
level design, often also referred to as mixed-
effects, nested or hierarchical designs
(Gelman and Hill, 2007), or more complex
structured designs, fail to recognise the fact that
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independence assumptions are unlikely to be
valid, and thus the reported analyses are also
unlikely to be valid. Statistical inferences made
from such analyses are often highly misleading.
UoA issues, as they are termed in the statisti-
cal literature (Altman and Bland, 1997), are not
limited to biomedical laboratory studies, and are
recognised as a major cause of concern more
generally for reported analyses in bioscience
and medicine (Aarts et al., 2014; Altman and
Bland, 1997; Bunce et al., 2014; Fleming et al.,
2013; Lazic, 2010; Calhoun et al., 2008;
Divine et al., 1992), and also feed into widely
acknowledged issues around the lack of repro-
ducibility and repeatability of much biomedical
research (Academy of Medical Sciences, 2017;
Bustin and Nolan, 2016; Ioannidis et al., 2014;
McNutt, 2014).
The RIPOSTE (Reducing IrreProducibility in
labOratory STudiEs) framework was established
to support the dialogue between scientists and
statisticians in order to improve the design, con-
duct and analysis of laboratory studies in bio-
medical sciences in order to reduce
irreproducibility (Masca et al., 2015). The aim of
this manuscript, which evolved directly from a
number of recommendations made by the
RIPOSTE framework, is to help laboratory scien-
tists identify potential UoA issues, to understand
the problems an incorrect analysis may cause
and to provide practical guidance on how to
undertake a valid analysis using the open source
R statistical software (R Core Team, 2016;
Ihaka and Gentleman, 1996). A simple intro-
duction to the basics of R is available from
Venables et al., 2017 and sources of informa-
tion on implementation of statistical methods in
the biosciences are widely available
(see, for example, Aho, 2014).
A simulation study is undertaken in order to
quantify losses in efficiency and inflation of the
false positive rate that an incorrect analysis may
cause (Appendix 1). The principles of experi-
mental design are briefly discussed, with some
general guidance on implemtation and good
practice (Appendix 2), and two example data-
sets are introduced as a means to highlight a
number of key issues that are widely misunder-
stood within the biomedical science literature.
Code in the R programming language is pro-
vided both as a template for those wishing to
undertake similar analyses and in order that all
results here can be replicated (Appendix 3);
script is available at Parsons, 2017. In addition,
a formal mathematical presentation of the most
common analysis error in this setting is also pro-
vided (Appendix 4).
Methods and materials
Background
A fundamental aspect of the design of all experi-
mental studies is a clear identification of the
experimental unit. By definition, this is the small-
est object or material that can be randomly and
independently assigned to a particular treatment
or intervention in the experiment (Mead et al.,
2012). The experimental unit is usually the unit
of statistical analysis and should provide infor-
mation on the study outcomes independent of
the other experimental units. Where here the
term outcome refers to a quantity or characteris-
tic measured or observed for an individual unit
in an experiment; most experiments will have
many outcomes (e.g. expression of multiple
genes, or mutiple assays) for each unit. The term
multiple outcomes refers to such situtations, but
is not the same as repeated outcomes (or more
often repeated measures) which refers to mea-
suring the same outcome at multiple time-
points. Experimental designs are generally
improved by increasing the number of (indepen-
dent) experimental units, rather than increasing
the number of observations within the unit
beyond what is require to measure within unit
variation with reasonable precision. If only a sin-
gle observation of a laboratory test is obtained
for each subject, data can be analysed using
conventional statistical methods provided all the
usual cautions and necessary assumptions are
met. However, if there are for instance multiple
observations of a laboratory test observed for
each subject (e.g. due to multiple testing, dupli-
cated analyses of samples or other laboratory
processes) then the analysis must properly take
account of this.
If all observations are treated equally in an
analysis, ignoring the dependency in the data
that arises from multiple observations from each
sample, this leads to inflation of the false posi-
tive (type I error) rate and incorrect (often highly
inflated) estimates of statistical power, resulting
in invalid statistical inference (see Appendix 1).
Errors due to incorrect identification of the
experimental unit were identified as an issue of
concern in clinical medicine more than 20 years
ago, and continue to be so (Altman and Bland,
1997). The majority of such UoA issues involve
multiple counting of measurements from individ-
ual subjects (experimental units); these issues
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have particular traction in for instance orthopae-
dics, ophthalmics and dentistry, where they typi-
cally result from measurements on right and left
hips, knees or eyes of a study participant or a
series of measurements on many teeth from the
same person.
The drive to improve standards of reporting
and thereby design and analysis of randomized
clinical trials, which resulted in the widely known
CONSORT guidelines (CONSORT GROUP (Con-
solidated Standards of Reporting Trials) et al.,
2001), has now expanded to cover many related
areas of biomedical research activity. For
instance, work by (Kilkenny et al., 2009)
highlighted poor standards of reporting of
experiments using animals, and made specific
mention of the poor reporting of the number of
experimental units; this work led directly to the
ARRIVE guidelines (Animal Research: Reporting
of In Vivo Experiments; Kilkenny et al., 2010)
that explicitly require authors to report the study
experimental unit when describing the design.
The recent Academy of Medical Sciences sympo-
sium on the reproducibility and reliability of bio-
medical research (Academy of Medical
Sciences, 2017) specifically highlighted poor
experimental design and inappropriate analysis
as key problem areas, and highlighted the need
for additional resources such as the NC3Rs
(National Centre for the Replacement, Reduction
and Refinement of Animals in Research) free
online experimental design assistant
(NC3Rs, 2017).
Design
The experimental unit should always be identi-
fied and taken into account when designing a
research study. If a study is assessing the effect
of an intervention delivered to groups rather
than individuals then the design must address
the issue of clustering; this is common in many
health studies where a number of subjects may
receive an intervention in a group setting or in
animal experiments where a group of animals in
a controlled environment may be regarded as a
cluster. This is also the case if a study is
designed to take repeated measurements from
individual subjects or units, from a source sam-
ple or replicate analyses of a sample itself. Indi-
viduals in a study may also be subject to
inherent clustering (e.g. family membership)
which needs to be identified and accounted for.
As a prelude to discussion of analysis issues,
it is important to distinguish between a number
of widely reported and distinct types of data
resulting from a variety of experimental designs.
The word subject is used here loosely to mean
the subject under study in an experiment and
need not necessarily be an individual person,
participant or animal.
i. Individual subjects: In many studies the
UoA will naturally be an individual sub-
ject, and be synonymous with the experi-
mental unit. A single measurement is
available for each subject, and inferences
from studies comprising groups of sub-
jects apply to the wider population to
which the individual subject belongs. For
example, a blood sample is collected
from n patients (experimental units) and
a haemoglobin assay is undertaken for
each sample. Statistical analysis com-
pares haemoglobin levels between
groups of patients, where the variability
between samples is used to assess the
significance of differences in means
between groups of patients.
ii. Groups of subjects: Measurements are
available for subjects. However, rather
than being an individual subject, the
experimental unit could be a group of
subjects that are exposed to a treatment
or intervention. In this case, inferences
from analyses of variation between
experimental units, apply to the groups,
but not necessarily to individual subjects
within the groups. For example, suppose
n m actively growing maize plants are
planted together at high density in
groups of size n in m controlled growing
environments (growth rooms) of varying
size and conditions (e.g. light and tem-
perature). Chlorophyll fluorescence is
used to measure stress for individual
plants after two weeks of growth. Due to
the expected strong competition
between plants, inferences about the
effects of the environmental interven-
tions on growth are made at the room
level only. Alternatively, in a different
experiment the same plants are divided
between growth rooms, kept spatially
separated in notionally exactly equivalent
conditions, after being previously given
one of two different high strength foliar
fertiliser treatments. Changes in plant
height (from baseline) are used to assess
the effect of the foliar interventions on
individual plants. Although the intention
was to keep growth rooms as similar as
possible, inevitably room-effects meant
that outcomes for individual plants
tended to be more similar if they came
from the same room, than if they came
from different rooms. In this setting the
plant is the experimental unit, but
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account needs to be made for the room-
effects in the analysis.
iii. Multiple measurements from a single
source sample: In laboratory studies, the
experimental unit is often a sample from
a subject or animal, which is perhaps
treated and multiple measurements
taken. Statistical inferences from analyses
of data from such samples should apply
to the individual tissue (source) from
which the sample was taken, as this is the
experimental unit. For example, consider
the haemoglobin example (i), if the assay
is repeated m times for each of the
n blood samples, then there would be
n m data values available for analysis.
The analysis should take account of the
fact that the replicate measurements
made for each sample tell us nothing
useful about the variability between sam-
ples, which are the experimental units.
iv. Multiple sub-samples from a single sam-
ple: Often a single sample from an
experimental unit is sub-divided and
results of assays or tests of these sub-
samples yield data that provide an
assessment of the variability between
sub-samples. It is important to note that
this is not the same as taking multiple
samples from an experimental unit. The
variability between experimental units is
not the same as, and must be distin-
guished from, variability within an experi-
mental unit and this must be reflected in
the analysis of data from such studies.
For example, n samples of cancerous tis-
sue (experimental unit) are each divided
into m sub-samples and lymph node
assays made for each. The variability
between the m sub-samples, for each of
the n experimental units, is not necessar-
ily the same as the variability that might
have been evident if more than one tis-
sue sample had been taken from each
experimental unit. This could be due to
real differences as the multiple samples
are from different sources, or batch-
effects due to how the samples are proc-
essed or treated before testing.
v. Repeated measures: One of the most
important types of experimental design
is the so-called repeated-measures
design, in which measurements are taken
on the same experimental unit at a num-
ber of time-points (e.g. on the same ani-
mal or tissue sample after treatment, at
more than one occasion). These multiple
measurements in time are generally
assumed to be correlated and regarded
as repeat measurements from an experi-
mental unit and not separate
experimental units. The likely autocorre-
lation between temporally related meas-
urements from the experimental units
should be reflected in the analysis of
such studies. For example, height meas-
urements for the n m plants in (ii) could
have been made at each of t occasions.
The t height measurements are a useful
means of assessing temporal changes for
individual plants (experimental unit), such
as the rate of increase (e.g. per day).
However, due to the likely strong correla-
tions, increasing the number of assess-
ment occasions will generally add much
less information to the analysis than
would be obtained by increasing the
number of experimental units.
Clearly many of these distinct design types
can be combined to create more complex set-
tings; e.g. plants might be housed together in
batches that cause responses from the plants in
the same batch to be correlated (batch-effects),
and samples taken from the plants, divided into
sub-samples, and processed at two different
testing centres, possibly resulting in additional
centre-effects. For such complex designs, it is
advisable to seek expert statistical advice, how-
ever the focus in the sections discussing analysis
is mainly on cases (ii), (iii) and (iv). Case (i) is han-
dled adequately by conventional statistical anal-
ysis, and although case (v) is important, it is too
large a topic to discuss in great depth here (see
e.g. (Diggle et al., 2013) for a wide ranging dis-
cussion of longitudinal data analysis). More gen-
eral design issues are discussed in Appendix 2.
Sample size
Power analysis provides a formal statistical
assessment of sample size requirements for
many common experimental designs; power
here is the probability (usually expressed as a
percentage) that the chosen test correctly
rejects the study null hypothesis, and is usually
set at either 80% or 90%. Many simple analytic
expressions exist for calculating sample sizes for
common types of design, particular for clinical
settings where methods are well developed and
widely used (Chow et al., 2008). Power
increases as the square root of the sample size
n, so power is gained by increasing n but at a
diminishing rate with n. Also power is inversely
related to the variance of the outcome s2, so
choosing a better or more stable outcome or
assay or test procedure will increase power.
For the most simple design with a normally
distributed outcome, comparing two groups of n
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subjects (e.g. as in Design case (i)), the sample
size is given by n ¼ 2s2  fðza=2 þ zbÞ
2=d2g,
where d is the difference we wish to detect, zb
represents the the upper 100 b standard nor-
mal centile, and 1  b is the power and a the
significance level; for the standard significance
of 5% and power of 90%,
ðza=2 þ zbÞ
2 ¼ ð1:96þ 1:28Þ2 » 10:5.
Where there are clusters of subjects (e.g. as
in Design case (ii)), then the correlation between
observations within clusters will have an impact
on the sample size (Hemming et al., 2011). The
conventional sample size expression needs to be
inflated by a variance inflation factor (VIF), also
called a design effect, given by
VIF ¼ 1þ ðm  1Þ  ICC, where there are m
observations in each cluster (e.g. a batch) and
ICC is the intraclass (within cluster) correlation
coefficient that quantifies the strength of associ-
ation between subjects within a cluster. The ICC
can either be estimated from pilot data or from
previous studies in the same area (see exam-
ples), or otherwise a value must be assumed. For
small cluster sizes (m<5) and intraclass correla-
tions (ICC<0:01), the sample size needs only to
be inflated by typically less than 10% (see
Table 1). However for larger values of both m
and ICC, sample sizes may need to be doubled,
trebled or more to achieve the required power.
For more complex settings, often the only
realistic option for sample size estimation is sim-
ulation. Raw data values are created from an
assumed distribution (e.g. multivariate normal
distribution with known means and covariances)
using a random number generator, and the
planned analysis performed on these data. This
process can be repeated many (usually thou-
sands of) times and the design characteristics
(e.g. power and type I error rate) calculated for
various sample sizes. This has typically been a
task that requires expert statistical input, but
increasingly code is available in R to make this
much easier (Green and MacLeod, 2016;
Johnson et al., 2015). Many application area
dependent rules of thumb exist when selecting a
sample size, the most general being the
resource equation approach of (Mead et al.,
2012), which suggests that approximately 15
degrees of freedom are required to estimate the
error variance at each level of an analysis.
Analysis
Incorrect analysis of data that have known or
expected dependencies leads to inflation of the
false positive rate (type I error rate) and invalid
estimates of statistical power, leading to incor-
rect statistical inference; a simulation study
(Appendix 1) shows how various design charac-
teristics can affect the properties of a hypotheti-
cal study. Focussing on linear statistical
modelling (McCullagh and Nelder, 1998), which
is by far the most widely used methodology for
analysis when reporting research in the biomedi-
cal sciences, there are generally two distinct
approaches to analysis when there are known
UoA issues (Altman and Bland, 1997).
Subject-based analysis
The simplest approach to analysis is to use a sin-
gle observation for each subject. This could be
achieved by selecting a single representative
observation or more usually by calculating a
summary measure for each subject. The sum-
mary measure is often the mean value, but could
be for instance the area under a response curve
or the gradient (rate) measure from a linear
model. Given that this results in a single obser-
vation for each subject, analysis can proceed
using the summary measure data in the conven-
tional way using a generalized linear model
(GLM; (McCullagh and Nelder, 1998)) assuming
independence between all observations.
A GLM relates a (link function) transformed
response variable to a linear combination of
explanatory variables via a number of model
parameters that are estimated from the
observed data. The explanatory variables are so-
Table 1. Variance inflation factors for cluster sizes (m) 2, 5, 10 and 20, and intraclass correlation
coefficients (ICC) 0.01, 0.05, 0.1 and 0.5.
m ICC
0.01 0.05 0.1 0.5
2 1.01 1.05 1.10 1.50
5 1.04 1.20 1.40 3.00
10 1.09 1.45 1.90 5.50
20 1.19 1.95 2.90 10.50
DOI: https://doi.org/10.7554/eLife.32486.002
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called fixed-effects that represent the (system-
atic) observed data that are used to model the
response variable. The lack of model fit is called
the residual or error, and represents unstruc-
tured deviations from the model predictions that
are beyond control. The subject-based approach
is valid but has the disadvantage that not all of
the available data are used in the definitive anal-
ysis, resulting in some lack of efficiency. Care
must be taken when choosing a single measure
for each subject, ensuring the selection does not
introduce bias and if a summary measure is gen-
erated, this value must be meaningful and if
appropriate the analysis should be weighted to
account for the precision in estimation of the
summary measure.
Mixed-effect analysis
A better approach than the subject-based analy-
sis, is a mixed-effect analysis (Galwey, 2014;
Pinheiro and Bates, 2000). A (generalized) lin-
ear mixed effects model (GLME) is an extension
of the conventional GLM, where structure is
added to the error term, leaving the systematic
fixed terms unchanged, by adding so-called ran-
dom-effect terms that partition the error term
into a set of structured (often nested) terms. In
the simplest possible setting
(Bouwmeester et al., 2013), the error term is
replaced by a subject-error term to model the
variation between subjects and a within-subject
error term to model the within subject variation.
This partition of the error into multiple strata
allows, for instance, the correct variability (sub-
ject-error term) to be used to compare groups
of subjects. Random-effects are often thought of
as terms that are not of direct inferential interest
(in contrast to the fixed-effects) but are such that
they need to be properly accounted for in the
model; e.g. a random selection of subjects or
centres in a clinical trial, shelves in an incubator
that form a temperature gradient or repeat
assays from a tissue sample.
The algorithms used to estimate the model
terms for a GLME and details of how to model
complex error structures will not be discussed
further, but more details can be found in for
instance Pinheiro and Bates, 2000. Mixed-
effects models can be fitted in most statistical
software packages, but the focus here is on the
R open source statistical software (R Core Team,
2016). Detailed examples of implementation
and code are provided in Appendix 3 and a
script is available at Parsons, 2017 to reproduce
all the analysis shown here using the R packages
nlme (Pinheiro et al., 2016) and lme4
(Bates et al., 2015).
Results
In order to better appreciate the importance of
UoA issues, to understand how these issues arise
and to show statistically how analyses should be
implemented, two example datasets from real
experiments are described and analysed in some
detail. The aims of the experiments are clearly
not of direct importance, but the logic, process
and conduct of the analyses are intended to be
sufficiently general in nature so as to elucidate
many key problematic issues.
Example 1: Adjuvant radiotherapy and
lymph node size in colorectal cancer
Six subjects diagnosed with colorectal cancer,
after confirmatory magnetic resonance imaging,
underwent neoadjuvant therapy comprising of a
short course of radiotherapy (RT) over one week
prior to resection surgery. These subjects were
compared with six additional cancer subjects, of
similar age and disease severity, who did not
receive the adjuvant therapy. The aim of the
study was to assess whether the therapy
reduced lymph node size in the resection speci-
men (i.e. the sample removed during surgery).
The resection specimen for each subject was
divided into two sub-samples after collection,
and each was fixed in formalin for 48-72 hr.
These sub-samples were processed and ana-
lysed at two occasions, by different members of
the laboratory team. The samples were sliced at
5mm intervals and images captured and ana-
lysed in an automated process that identified
lymph node material which was measured by a
specialist pathologist to give a measure of indi-
vidual lymph node size (i.e. diameter), based on
assumed sphericity. Three slices per sub-sample
were collected for each subject. Table 2 shows
the measured lymph node sizes in mm for each
sample.
Naive analysis
The simplest analysis and the one that may
appear to be correct if no information on the
design or data structure shown in Table 2 were
known, would be a t-test that compares the
mean lymph node size between the RT groups.
This shows that there is reasonable evidence to
support a statistically significant difference in
mean lymph node size between those subjects
who received RT (Short RT) and those who did
not (None); mean in group None = 2.403 mm
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and in group RT Short = 2.120 mm, difference in
means = 0.283 mm (95% CI; 0.057 to 0.508),
with a t-statistic = 2.501 on 70 degrees of free-
dom, and a p-value = 0.015. The conclusion
from this analysis is that lymph node sizes were
statistically significantly smaller in the group that
had received adjuvant RT. Why should the verac-
ity of this result be questioned?
The assumptions made when undertaking any
statistical analysis must be considered carefully.
The t-statistic is calculated as the absolute value
of the difference between the group means,
divided by the pooled standard error of the dif-
ference (sed) between the group means. This lat-
ter quantity is given by sed ¼ s
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ð1=n1 þ 1=n2Þ
p
,
where n1 and n2 are the sample sizes in the two
groups and s2 is the pooled variance given by
s2 ¼ ððn1   1Þs
2
1
þ ðn2   1Þs
2
2
Þ=ðn1 þ n2   2Þ; where
s2
1
and s2
2
are the variances within each group.
The important thing to realize here is that the
variances within each of the RT groups are calcu-
lated by simply taking the totality of data for all
six subjects in each group, across all sample
types and slices. One of the key assumptions of
the t-test is that of independence. Specifically,
this requires the lymph node sizes to be all inde-
pendent of each other; i.e. the observed size for
one particular node is not systematically related
to the other lymph node size data used for the
statistical test. What is meant by related to in
this context?
It seems highly likely that the lymph node
sizes for repeat slices for any particular sample
for a subject are more similar than size measure-
ments from other subjects. Similarly, it might be
expected that lymph node sizes for the two sam-
ples for each subject are more similar than
lymph nodes size measurements from other sub-
jects. If the possibility that this is important is
ignored, and a t-test is undertaken, then the var-
iability measured between samples and between
slices within samples is being used to assess dif-
ferences between subjects. If the assumption of
independence is not valid, then by ignoring this,
claims for statistical significance may be being
made that are not supported by the data (See
Appendix 4 for a mathematical description of
the naive analysis).
Subject-based analysis
Given that the lymph node size measurements
within samples and subjects are likely to be
more similar to each other than to data from
other subjects, how should the analysis be con-
ducted? Visual inspection of the data can often
reveal patterns that are not apparent from tabu-
lar summaries; Figure 1 shows a strip plot of the
data from Table 2.
It is clear, from a visual inspection alone of
Figure 1, that data from repeat slices within
samples are more similar (clustered together)
than data from the repeat samples within each
subject. And also that data from the multiple
samples and slices for each subject are generally
clustered together; data from a single subject
are usually very different from other subjects,
Table 2. Lymph node sizes (mm), by sample slice and subject, by radiotherapy (RT) group, subjects 1 to 6 no RT and subjects 7 to 12
short RT; highlighted cells are those removed to unbalance the design.
None Short RT
Subject Sample Slice Subject Sample Slice
1 2 3 1 2 3
1 1 1.71 1.98 1.88 7 1 2.37 2.36 2.20
2 1.72 1.98 1.85 2 2.36 2.62 2.60
2 1 2.51 2.55 2.65 8 1 1.33 1.35 1.15
2 2.98 3.20 2.80 2 1.90 1.87 1.85
3 1 1.69 1.72 1.80 9 1 1.70 1.78 1.78
2 1.82 1.97 1.73 2 2.07 1.76 1.85
4 1 1.72 1.78 2.04 10 1 2.23 2.14 2.21
2 2.50 2.65 2.77 2 2.50 2.33 2.16
5 1 3.32 3.27 3.07 11 1 2.10 1.89 1.75
2 3.11 3.03 3.11 2 2.11 2.16 2.12
6 1 2.33 2.48 2.53 12 1 2.58 2.54 2.59
2 2.86 2.87 2.52 2 2.77 2.65 2.60
DOI: https://doi.org/10.7554/eLife.32486.003
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irrespective of the RT grouping. One, albeit
crude, solution to such issues is to calculate a
summary measure for each of the experimental
units at the level at which the analysis is made,
and use these measures for further analysis. The
motivation for doing this is that it is usually rea-
sonable to assume that experimental units (sub-
jects) are independent of one another, so if a
t-test is undertaken on summary measures from
each of the twelve subjects it is also reasonable
to assume that the necessary assumption of
independence is true.
Using the mean lymph node size for each
subject as the summary measure (subjects 1 to
12; 1.85, 2.78, 1.79, 2.24, 3.15, 2.60, 2.42, 1.57,
1.82, 2.26, 2.02, and 2.62 mm), a t-test shows
that there is no evidence to support a statisti-
cally significant difference in mean lymph node
size between those subjects who received RT
(Short RT) and those who did not (None); mean
in group None = 2.403 mm and in group RT
Short = 2.120 mm, difference in means = 0.283
mm (95% CI; -0.321 to 0.886), with a t-statistic =
1.043 on 10 degrees of freedom, and a p-value
= 0.322. Note that the group means are the
same but now the t-statistic is based on 10
degrees of freedom, rather than the 70 of the
naive analysis, and the confidence interval is con-
siderably wider than that estimated for the naive
analysis. The conclusion from this analysis is that
there is no evidence to support a difference in
lymph node size between groups. Why is the
Figure 1. A strip plot showing observed lymph node size data by subject (1-12) and sample, after none and a
short course of radiotherapy (Short RT).
DOI: https://doi.org/10.7554/eLife.32486.004
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result of this t-test so different from the previous
naive analysis?
In the naive analysis the variability between
measurements within the main experimental
units (subjects) and the variability between
experimental units was used to assess the differ-
ence between experimental units. In the analysis
in this section the variability between experimen-
tal units alone has been used to assess the effect
of the intervention applied to the experimental
units. The multiple measurements within each
experimental unit improve the precision of the
estimate of the unit mean, but provide no infor-
mation on the variability between units, that is
important in assessing interventions that are
applied to the experimental units. This analysis is
clearly an improvement on the naive analysis,
but it uses only summary measures for each
experimental unit, rather than the full data, it
tells us nothing about the relative importance of
the variability between subjects, between sam-
ples and between slices and it does not allow us
to assess the importance of these design factors
to the conclusions of the analysis.
Linear mixed-effects analysis
To correctly explain and model the lymph node
data a linear mixed-effects model must be used.
The experimental design used in the lymph
node study provides the information needed to
construct the random-effects for the mixed-
effects model. Here there are multiple levels
within the design that are naturally nested within
each other; samples are nested within subjects,
and slices are nested within samples. Fitting
such a mixed-effects model gives the following
estimate for the intervention effect (RT treat-
ment groups); difference in means = 0.283 mm
(95% CI; -0.321 to 0.886), with a p-value = 0.322
(t-statistic = 1.043 on 10 degrees of freedom).
For a balanced design, intervention effect esti-
mates for the mixed-effects model are equiva-
lent to those from the subject-based analysis. A
balanced design is one where there are equal
numbers of observations for all possible combi-
nations of design factor levels; in this example
there are the same number of slices within sam-
ples and samples within subjects.
The mixed effects model allows the variability
within the data to be examined explicitly. Out-
put from model fitting also provides estimates
of the standard deviations of the random effects
for each level of the design; these are for sub-
jects, sP = 0.436 (95% CI; 0.262 to 0.727), sam-
ples sS = 0.236 (95% CI; 0.151 to 0.362) and
residuals (slices) s = 0.122 (95% CI; 0.100 to
0.149). Squaring to get variances, indicates that
the variability, in lymph node size, between sub-
jects was three and half times more than the var-
iability between samples, and nearly thirteen
times as much as the variability between repeat
slices within samples. The intraclass correlation
coefficient measures the strength of association
between units within the same group; for sub-
jects ICCP = 0.733, where
ICCP ¼ s
2
P=ðs
2
P þ s
2
S þ s
2
 Þ. This large value,
which represents the correlation between two
randomly selected observations on the same
subject, shows why the independence assump-
tion required for the naive analysis is wrong (i.e.
independence implies that ICC = 0). This dem-
onstrates clearly why pooling variability without
careful thought about the sampling strategy and
design of an experiment is unwise, and likely to
lead to erroneous conclusions.
Various competing models for random effects
can be compared using likelihood ratio tests
(LRT). For instance in this example suppose that
the two samples collected for the same subject
had been arbitrarily labelled as sample 1 and
sample 2, and in practice there was no real dif-
ference in the methods used to process or cap-
ture images of nodes from the two samples. In
such a setting, a more appropriate random
effects model may be to have a subject effect
only and ignore the effects of samples within
subjects. Constructing such a model and com-
paring to the more complex model gives a LRT
= 39.92 and p-value < 0.001, providing strong
support in favour of the full multilevel model.
Diagnostic analyses can be undertaken after fit-
ting mixed-effects model, in an analogous man-
ner to linear models (Fox et al., 2011).
Figure 2 shows boxplots of residuals for each
subject and a quantile-quantile plot to assess
Normality of the residuals. Inspection of the
residual plots for the lymph node size data,
show that assumptions of approximate Normal-
ity are reasonable; e.g. the quantile-quantile
plot of the residuals from the model fit fall
(approximately) along a straight line when plot-
ted against theoretical residuals from a Normal
distribution. If residuals fail to be so well
behaved and deviate in a number of well under-
stood ways, or if for instance variances are non-
equal or vary with the outcome (heterogeneity),
then transforming the data prior to linear mixed-
effects analysis can improve the situation (Man-
giafico, 2017). However, in general, if the Nor-
mality assumption is not sustainable, data are
better analysed using generalized linear mixed
effects models (Pinheiro and Bates, 2000;
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Galwey, 2014), that better account for the
distributional properties of the data.
Unbalanced data analysis
Intervention effect estimates for the mixed-
effects and subject-based analyses presented
here are equivalent, due to the balanced nature
of the design. Every subject has complete data
for all samples and slices. By calculating means
for each subject averaging occurs across the
same mix of samples and slices, so irrespective
of the effects on the analysis of these factors,
the means will be directly comparable and esti-
mated with equivalent precision. Whilst balance
is a desirable property of any experimental
design, it is often unrealistic and impractical to
obtain data structured in this way; for instance in
this example, samples may be contaminated or
damaged during processing or insufficient mate-
rial may be available for all three slices.
Repeating the above mixed-effects analysis
after randomly removing 50% of the data (see
Table 2), gives an estimated difference in lymph
node size between groups = 0.263 mm (95% CI;
-0.397 to 0.922), with a p-value = 0.391, and
estimates of the standard deviations of the ran-
dom effects for each level of the design, sP ¼
0:421 (95% CI; 0.224 to 0.794), sS ¼ 0:279 (95%
Figure 2. Boxplots of residuals (observed values - fitted values) for each subject; symbols (.) are medians, boxes
are interquartile ranges (IQR), whiskers extend to 1.5IQR and symbols () outside these are suspected outliers
(a). Quantile-quantile (Q–Q) plot of the model residuals () on the horizontal axis against theoretical residuals from
a Normal distribution on the vertical axis (b).
DOI: https://doi.org/10.7554/eLife.32486.005
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CI; 0.160 to 0.489) and s ¼ 0:124 (95% CI; 0.088
to 0.174). These are, perhaps surprisingly given
that only half the data from the previous analysis
are being used, very similar to estimates from
the complete data. However, in the unbalanced
setting the subject-based analysis is no longer
valid, as it ignores the variation in sample sizes
between subjects; the estimated difference in
lymph node size between groups is 0.199 mm
(95% CI; -0.474 to 0.872) for the subject-based
analysis.
Example 2: Lymph node counts after
random sampling
The most extreme example of non-normal data
is for binary responses, which generally results
from yes/no or present/absence type outcomes.
Extending the lymph node example, in a parallel
study, rather than measure the sizes of selected
nodes or conduct a time-consuming count of all
nodes, a random sampling strategy was used to
select regions of interest (RoI) in which fives
nodes were randomly selected and compared to
a 2mm reference standard (2mm; yes or no).
This could be done rapidly by a non-specialist.
Five samples were processed for each of twelve
subjects, in an equivalent design to the lymph
node size study; data are shown in Table 3.
Non-normal data analysis
For some subjects there was insufficient tissue
for five samples, resulting in an unbalanced
design. The odds of an event (i.e. observing or
not observing a lymph node with diameter
2mm), is the ratio of the probabilities of the
two possible states of the binary event, and the
odds ratio is the ratio of the odds in the two
groups of subjects (e.g. those receiving either
None or Short RT). A naive analysis of these
data suggest an estimate of the odds ratio of
(43/82)/(79/46) = 0.31, for RT Short versus None
groups; 43 lymph nodes with maximum diame-
ters 2mm from 125 in the RT Short group ver-
sus 79 from 125 in the None group. Being in the
RT Short group results in a lower odds of lymph
nodes with diameters 2mm. This is the result
one would obtain by conventional logistic
regression analysis; odds-ratio 0.31 (95% CI;
0.18 to 0.51; p-value < 0.001) providing very
strong evidence that lymph node diameters
were lower in the RT Short group.
In logistic regression analysis the estimated
regression coefficients are interpreted as log
odds-ratios, which can be transformed to odds
ratios using the exponential function
(Hosmer et al., 2013). However, one should be
instinctively cautious about this result, as it is
clear from Table 3 that variation within subjects
is much less than between subjects; i.e. some
subjects have low counts across all samples and
others have high counts across all samples. The
above analysis ignores this fact and pools varia-
tion between samples and between subjects to
test for differences between two groups of sub-
jects. This is clearly not a good idea.
Fitting a GLME model with a subject random
effect, gives an estimated odds-ratio for the
Short RT group of 0.26 (95% CI; 0.09 to 0.78;
p-value = 0.016). The predicted probability of
detecting a lymph node with a diameter 2mm
was 0.65 for the None RT group and 0.33 for the
Short RT. The overall conclusions of the study
have not changed, however the level of signifi-
cance associated with the result is massively
overstated in the simple logistic regression, due
to the much smaller estimate of the standard
error of the log odds-ratio (0.264 for logistic
regression versus 0.564 for the mixed-effects
logistic regression). By failing to properly
account for the difference in variability between
Table 3. Number of five selected lymph nodes with maximum diameters 2mm, for up to five tissue samples per subject (1-12), after
either none or a short course of radiotherapy (Short RT).
None Short RT
Subject Sample Subject Sample
1 2 3 4 5 1 2 3 4 5
1 4 4 - - - 7 1 0 0 0 0
2 3 4 5 2 - 8 1 2 - - -
3 2 3 3 2 - 9 1 0 1 0 2
4 2 4 1 2 1 10 2 1 4 0 2
5 3 4 4 3 5 11 4 2 4 3 3
6 2 5 5 3 3 12 3 4 3 - -
DOI: https://doi.org/10.7554/eLife.32486.006
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measurements made on the same subject rela-
tive to the variability in measurements between
subjects results in overoptimistic conclusions.
Discussion
The examples, simulations and code provided
highlight the importance of correctly identifying
the UoA in a study, and show the impact on the
study inferences of selecting an inappropriate
analysis. The simulation study (Appendix 1)
shows that the false positive rate can be
extremely high and efficiency very low if analyses
are undertaken that do not respect well known
statistical principles. The examples reported are
typical of studies in the biomedical sciences and
together with the code provide a resource for
scientists who may wish to undertake such analy-
ses (Appendix 3). Although clearly discussion
with a statistician, at the earliest possible stage
in a study, should always be strongly encour-
aged, in practice this may not be possible if sta-
tisticians are not an integral part of the research
team. The RIPOSTE framework (Masca et al.,
2015) called for the prospective registration
(Altman, 2014) and publication of study proto-
cols for laboratory studies, which we believe if
implemented would go a long way towards
addressing many of the issues discussed here by
causing increased scrutiny at all stages of an
experimental study.
The examples, design and analysis methods
presented here have deliberately used terminol-
ogy such as experimental unit, subject and sam-
ple to make the arguments more
comprehensible, particularly for non-statisticians,
who often find these topics conceptually much
easier to understand using such language. This
may have contributed to the widespread belief
amongst many laboratory scientists that these
issues are important only in human experimenta-
tion. Where, for instance, the subject is a partici-
pant in a clinical trial and the idea that subjects
provide data that are independent of one
another, but correlated within a subject seems
perfectly natural. However, although such lan-
guage is used here, it is important to emphasise
that the issues discussed apply to all experimen-
tal studies and are arguably likely to be more
not less important for laboratory studies than for
human studies. The lack of appreciation of the
importance of UoA issues in laboratory science
may be due to the misconception that the within
subject associations observed for human sub-
jects arise mainly from the subjective nature of
the measures used in clinical trials on human
subjects; e.g. patient-reported outcomes. Con-
trasting these with the more objective (hard)
measures that dominate in much biomedical lab-
oratory based science leads many to assume
that that these issues are not important when
analysing data and reporting studies in their own
research area.
Mixed-effects models are now routinely used
in the medical and social sciences (where they
are often known as multilevel models), to for
instance allow for the clustering in patient data
from a recruiting centre in a clinical trial, or to
model the association in outcomes within
schools and classrooms from students
(Brown and Prescott, 2015; Snijders and
Bosker, 2012). Mixed-effects models originated
from the work of pioneering statistician/geneti-
cist R. A. Fisher (Fisher, 1919), whose classic
texts on experimental design have led to their
extensive and very early use in agricultural field
experimentation (Mead et al., 2012). However,
the use of mixed-effects models in the biological
sciences has not spread from the field to the
laboratory.
Mixed-effects models are not used as widely
in biomedical laboratory studies as in many
other scientific disciplines, which is a concern, as
given the nature of the experimental work
reported one would expect these models to be
equally widely used and reported as they are
elsewhere. This is most likley simply a matter of
lack of knowledge and convention; if colleagues
or peers do not routinely use these methods
then why should I? By highlighting the issue and
providing some guidance the hope is that this
article may address the first of these issues.
Journals and other interest groups (e.g. funding
bodies and learned societies) have a part to play
also, particularly in ensuring that work is
reviewed by experienced and properly qualified
statisticians at all stages from application to
publication (Masca et al., 2015).
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Appendix 1
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Simulation study: Demonstrating UoA issues
Consider a small hypothetical study that aims to compare outcomes from subjects randomly
allocated to two contrasting treatment options, A and B. Samples were collected from
subjects and detailed laboratory work undertaken to provide 24 outcome measurements for
each of the two groups. For treatment group A, a measurement was obtained from 24
individual subjects; measurements for group A are known to be uncorrelated, i.e. independent
of one another. However, for treatment group B no such information was available. How
would the sampling strategy for group B impact on the analysis undertaken and how could it
affect the interpretation of the results of the analysis?
Consider the following possibilities; (i) the sampling strategy used for treatment group B
was the same as treatment group A (i.e. 24 independent samples), (ii) in group B 2
measurements were available from each of 12 subjects, (iii) 4 measurements were available
from each of 6 subjects, (iv) 6 measurements were available from each of 4 subjects, (v) 8
measurements were available from each of 3 subjects and (vi) 12 measurements were available
from each of 2 subjects.
Experience from previous studies suggests that the measurements made on the same
individual subjects are likely to be positively correlated; i.e. if one measurement is large then
the others will also be large, or conversely if one measurement is small others will also be
small.
Assume for the ease of illustration that the measurements were Normally distributed, and
of equal variance in each treatment group, and analyses were made using an independent
samples t-test, at the 5% level. One key characteristic that is important here is the false
positive rate (type I error rate); i.e. the probability of incorrectly rejecting the null hypothesis.
Here the null hypothesis is that the sample mean from treatment groups A and B are the
same. Figure 1(a) shows the type I error rates, based on 100000 simulations, for comparison of
groups A and B, where the null hypothesis is known to be true, for scenarios (i) - (vi) for within
subject correlations  = 0,  = 0.2,  = 0.5 and  = 0.8. If data within subjects are uncorrelated
( = 0), then the type I error rate is maintained at the required 5% level over all scenarios (i) to
(vi), and clearly in scenario (i), where there are 24 single samples in group B, it makes no sense
to consider within subject correlations as there is only a single measurement for each subject,
the type I error rate is controlled at the 5% level. Otherwise, as the number of subjects gets
smaller (greater clustering) and the correlation within subjects gets larger, the type I error rate
increases rapidly. In the extreme scenario where there are data from 2 subjects only, with a
high correlation ( = 0.8) the null hypothesis is incorrectly rejected approximately 45% of the
time.
If grouped data are naively analysed, ignoring likely strong associations between
measurements within the same group, it is very likely that incorrect inferences are made about
differences between treatment groups.
If the true grouping structure in B were known, then how might this be properly accounted
for in the analysis? One simple option to improve on the naive analysis, of assumed
independence, is to randomly select a single value from each subject; this will control the type
I error rate at the required level across all scenarios and correlations (Figure 1b), but will
provide rather inefficient estimates of the treatment difference between groups (Figure 1c).
An alternative simple strategy is to calculate the within-subject means, this provides an
unduly conservative (type I error rate 5%) test (Figure 1b), as the true variability in the data
is typically underestimated by using the subject means. However, the analysis based on
subject means rather than randomly selected values provides more efficient estimates of the
treatment difference between groups (Figure 1(c)), with the efficiency depending on the within
subject correlation; as the correlation within subjects increases then the value of calculating a
mean, in preference to selecting a single value for each subject, diminishes markedly.
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Appendix 1—figure 1. Naive use of a conventional t-test on correlated (grouped by subject)
data,  = 0 (black circle ),  = 0.2 (red circle)  = 0.5 (blue circle) and  = 0.8 (green circle),
inflates the type I error rate (set at 5%). (a). The type I error rate can be controlled to the
required level by randomly selecting a single measurement for each subject,  = 0
(black circle),  = 0.2 (red circle),  = 0.5 (blue circle) and  = 0.8 (green circle), or made
conservative (5%) by taking the mean of the measurements for each subject,  = 0
(black open circle),  = 0.2 (red open circle),  = 0.5 (blue open circle) and  = 0.8
(green open circle) (b). The relative efficiency of treatment effect estimates declines as the
number of clusters become smaller and is always higher for the mean than the randomly
selected single measurement strategy (c). The scenarios (i) – (vi) are as described in the text.
DOI: https://doi.org/10.7554/eLife.32486.008
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Appendix 2
DOI: https://doi.org/10.7554/eLife.32486.009
Some fundamental principles of experimental design
Appendix 2—figure 1. Design options for a putative laboratory study testing n samples of
experimental material.
DOI: https://doi.org/10.7554/eLife.32486.010
Consider a putative study (Figure 1), where n samples (experimental units) of material are
available for experimentation. Interventions (A and B) are assigned to the experimental units
and sub–samples collected for processing and incubation prior to final testing 48 hours later.
The scientist undertaking the study has control over the sampling strategy and the design; e.g.
how to allocate samples to A and B, whether to divide samples and how to split material
between incubators and the testing procedures used for data collection. What are the key
issues that they need to consider before proceeding to do the study?
1. If possible, always randomly assign interventions to experimental units. Randomization
ensures, on average, that there is balance for unknown confounders between interventions
2. A confounder is a variable that is associated with both a response and explanatory variable,
and consequently causes a spurious association between them. For example, if all samples
for intervention A were stored in incubator 1 and all samples for B were stored in incubator
2, and the incubators were found to be operating at different temperatures, then are the
observed effects on the outcome due to the interventions or the differences in temperature
between incubators? We do not know, as the effects of the interventions and temperature
(incubators) are fully confounded
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3. If there are known confounding factors, it is always a good idea to modify the design to
take account of these; e.g. by blocking
4. Blocking involves dividing experimental units into homogenous subgroups (at the start of
the experiment) and allocating (randomizing) interventions to experimental units within
blocks so that the numbers are balanced; e.g. interventions A and B are split equally
between incubators.
5. Blocking a design to protect against any suspected (or unsuspected) effects on the out-
comes caused by processing, storage or assessment procedures is always a good idea; e.g.
if more than one individual performs assays, or more than one instrument is used then split
interventions so as to obtain balance.
6. In general, it is always better to increase the number of sample experimental units than the
number of sub–samples. Study power is directly driven by the number of experimental units
n.
7. Increasing the number of sub-samples m helps to improve the precision of estimation of the
sample effect and allows assay error to be assessed, but has only an indirect effect on study
power. Usually there is little benefit to be gained by making m much greater than five.
8. If there are two interventions, then it is always best to divide experimental units equally
between interventions. If the aim of an experiment is to compare multiple interventions to a
standard or control intervention then it is to better to allocate more experimental units to
the standard arm of the study. For example, if a third standard arm (S) were added to the
study, in addition to A and B, then it would be better (optimal) to allocate samples in the
ratio 2:1:1 to interventions S:A:B.
9. All others things being equal, a better design is obtained if the variances of the explanatory
variables are increased, as this is likely to provide a larger effect on the study outcomes. For
example, suppose A and B were doses of a drug and a higher dose of the drug resulted in
a larger value of the primary study outcome. If the doses for A and B were set at the
extremes of the normal range, then the effect on the primary outcome is likely to be much
larger than if the doses were only marginally different.
10. If a number of design factors are used then try and make sure that they are independent
(uncorrelated). For example, the current design has a single design factor comprising two
doses of a drug (A and B). If a second design factor were added, e.g. intravenous (C) or oral
delivery (D), then crossing the factors such that the experimental samples are split (evenly)
between the four combination A.C, A.D, B.C and B.D provides the optimal design. The fac-
tors are independent; using the terminology of experimental design, they are orthogonal.
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Appendix 3
DOI: https://doi.org/10.7554/eLife.32486.011
R code for examples
R is an open source statistical software package and programming language (R Core Team,
2016; Ihaka and Gentleman, 1996) that is used extensively by statisticians across all areas of
scientific research and beyond. The core capabilities of R can be further extended by user
developed code packages for very specific methods or specialized tasks; many thousands of
such packages exist and can be easily installed by the user from The Comprehensive R Archive
Network (CRAN) (CRAN, 2017) during an R session. Many excellent introductions to the basics
of R are available online and from CRAN (Venables et al., 2017), so here the focus is on usage
for fitting the models described in the main text with notes on syntax and coding restricted to
implementation of these only. A script is available at Parsons, 2017 to replicate all the analyses
reproduced here.
The first dataset considered here is that for the adjuvant radiotherapy and lymph node size in
colorectal cancer example. For small studies such as this, data can be entered manually into an R
script file, by assigning individual observed data variables to a number of named vectors, using
the <- operator, and combining together into a data frame (data.frame function), which is the
simplest R object for storing a series of data fields which are associated together.
> LNsize < c(1.71, 1.72, 1.98, 1.98, 1.88, 1.85, 2.51, 2.98,
2.55, 3.20, 2.65, 2.80, 1.69, 1.82, 1.72, 1.97,
1.80, 1.73, 1.72, 2.50, 1.78, 2.65, 2.04, 2.77,
3.32, 3.11, 3.27, 3.03, 3.07, 3.11, 2.33, 2.86,
2.48, 2.87, 2.53, 2.52, 2.37, 2.36, 2.36, 2.62,
2.20, 2.60, 1.33, 1.90, 1.35, 1.87, 1.15, 1.85,
1.70, 2.07, 1.78, 1.76, 1.78, 1.85, 2.23, 2.50,
2.14, 2.33, 2.21, 2.16, 2.10, 2.11, 1.89, 2.16,
1.75, 2.12, 2.58, 2.77, 2.54, 2.65, 2.59, 2.60)
> Subject <- factor(rep(1:12, each = 6), levels = 1:12)
> Sample <- factor(rep(1:2, times = 36), levels = 1:2)
> Slice <- factor(rep(rep(1:3, each = 2), times = 12), levels = 1:3)
> RadioTherapy <- factor(rep(1:2, each = 36), levels = 1:2,
labels = c("None", "RTShort"))
> LymphNode < data.frame(Subject, Sample, Slice,
RadioTherapy, LNsize)
The factors define the design of the experiment, and are built using the rep function that
allows structures to be replicated in a concise manner. The first 6 rows of the data frame
LymphNode can be examined using the head function.
> head(LymphNode, n = 6)
Subject Sample Slice RadioTherapy LNsize
1 1 1 1 None 1.71
2 1 2 1 None 1.72
3 1 1 2 None 1.98
4 1 2 2 None 1.98
5 1 1 3 None 1.88
6 1 2 3 None 1.85
This is the standard rectanguler form that will be familiar to those who use other statistical
software packages or spreadsheets for data storage. More generally data can be read
(imported) into R from a wide range of data formats; for instance if data were laid out as above
in a spreadsheet programme it could be saved in comma separated format (csv) (e.g. data.csv)
and read into R using the following code LymphNode <- read.csv("data.csv"). Naive analysis of
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data LymphNode would be implemened using the t.test function
> t.test(LNsize ~ RadioTherapy, var.equal = TRUE, data = LymphNode)
Two Sample t-test
data: LNsize by RadioTherapy
t = 2.501, df = 70, p-value = 0.01473
alternative hypothesis: true difference in means is not equal to 0
95 percent confidence interval:
0.05721632 0.50778368
sample estimates:
mean in group None mean in group RTShort
2.402778 2.120278
This is equivalent to fitting a linear regression model using the R linear model function lm,
other than a change in the direction of the differencing of the group means. The R formula
notation y ~ x symbolically expresses the model specification linking the response variable y to
explanaory variable x; here the response variable is lymph node size LNsize and the
explanatory variable is the radiotheraphy treatment RadioTherapy. A full report of the fitted
model object mod can be seen using the summary(mod) function. For brevity, the full output
is not shown here, but rather individual functions are used to display particular aspects of the
fit; e.g. for coefficients coef(mod), confidence intervals confint(mod) and an analysis of
variance table anova(mod).
> mod <- lm(LNsize ~ RadioTherapy, data = LymphNode)
> anova(mod)
Analysis of Variance Table
Response: LNsize
Df Sum Sq Mean Sq F value Pr(>F)
RT.means 1 0.23942 0.23942 1.0868 0.3217
Residuals 10 2.20293 0.22029
---------
Signif. codes: 0 ***  0.001 **  0.01 *  0.05 .  0.1   1
> cbind(coef(mod), confint(mod))
2.5% 97.5%
(Intercept) 2.402778 2.2434782 2.56207740
RadioTherapyRTShort -0.282500 -0.5077837 -0.05721632
Th analysis by subject proceeds by first calculating lymph node size means for each subject,
LNsize.means, using the tapply and mean functions, prior to fitting the linear model, including
the new RT.means factor. There is now no need to specify a data frame using the data
argument to lm, as response and explanatory variables are newly created objects themselves,
so R can find them without having to look within a data frame, as was the case for the previous
model.
> LNsize.means <- tapply(LymphNode$LNsize, list(LymphNode$Subject),
mean, na.rm = TRUE)
> RT.means <- factor(rep(1:2, each = 6), levels = 1:2,
labels = c("None", "RTShort"))
> mod.lm <- lm(LNsize.means ~ RT.means)
> anova(mod.lm)
Analysis of Variance Table
Response: LNsize.means
Df Sum Sq Mean Sq F value Pr(>F)
RT.means 1 0.23942 0.23942 1.0868 0.3217
Residuals 10 2.20293 0.22029
> cbind(coef(mod.lm), confint(mod.lm))
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2.5% 97.5%
(Intercept) 2.402778 1.975837 2.829718
RT.meansRTShort -0.282500 -0.886285 0.321285
The linear mixed-effects package nlme must be installed before proceeding to model
fitting. The model syntax for fitting these models is similar to standard linear models in most
respects, with the addition of a random argument to describe the structure of the data. Full
details of how to specify the model can be found in standard texts such as (Pinheiro and
Bates, 2000). Confidence intervals of fixed and random effects are provided using the
intervals command.
> install.packages("nlme")
> library(nlme)
> mod.lme <- lme(LNsize ~ RadioTherapy,
random = ~ 1 | Subject / Sample, data = LymphNode)
> anova(mod.lme)
numDf denDF F value p-value
(Intercept) 1 48 278.60135 <0.0001
RadioTherapy 1 10 1.08682 0.32177
> intervals(mod.lme, which = "fixed")
Approximate 95% confidence intervals
Fixed effects:
lower est. upper
(Intercept) 2.0175137 2.402778 2.7880418
RadioTherapyRTShort -0.8862853 -0.282500 0.3212853
attr(,"label")
[1]"Fixed effects:"
> intervals(mod.lme, which = "var-cov")
Approximate 95% confidence intervals
Random Effects:
Level: Subject
lower est. upper
sd((Intercept)) 0.2619509 0.4364928 0.7273346
Level: Sample
lower est. upper
sd((Intercept)) 0.1509095 0.2335944 0.3615832
Within-group standard error:
lower est. upper
sd((Intercept)) 0.09995826 0.12209407 0.14913186
Competing models can be compared using likelihood ratio tests.
> mod0.lme <- update(mod.lme, random = ~ 1 | Subject)
> anova(mod0.lme, mod.lme)
Model df AIC BIC logLik Test L.Ratio p-value
mod0.lme 1 4 108.71 117.71 -50.36
mod.lme 2 5 -3.9473 7.2952 6.97 1 vs 2 114.66 <0.0001
Model fit can be explored using a range of diagnostic plots. For instance, standardized
residuals versus fitted values by subject,
> plot(mod.lme, resid(., type = "response") ~ fitted(.)
| Subject, abline = 0))
observed versus fitted values by subject,
> plot(mod.lme, LNsize ~ fitted(.) | Subject, abline = c(0,1))
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box-plots of residuals by subject,
> plot(mod.lme, Subject resid(.), aspect = 1)
and quantile-quantile plots.
> qqnorm(resid(mod.lme, type = "response"), pch = 19, col = 1,
main = NULL, las = 1)
> qqline(resid(mod.lme, type = "response"), lty = 2)
For the sake of exposition, creating an unbalanced dataset from the original LymphNode
data is achieved by randomly removing some data values and re-fitting the mixed-effects
model.
> set.seed(8845391)
> remove.cells <- sample(1:72, 36, replace=FALSE)
> Unbalanced.LymphNode <- LymphNode[setdiff(1:72, remove.cells),]
> umod.lme <- lme(LNsize ~ RadioTherapy,
random = ~ 1 | Subject / Sample, data = Unbalanced.LymphNode)
> anova(umod.lme)["RadioTherapy",]
numDf denDF F value p-value
RadioTherapy 1 9 0.8122484 0.3909
> intervals(umod.lme, which = "fixed")[["fixed"]][2,]
lower est. upper
-0.9217043 -0.2625918 0.3965206
> intervals(umod.lme, which = "var-cov")
Approximate 95% confidence intervals
Random Effects:
Level: Subject
lower est. upper
sd((Intercept)) 0.2235331 0.4213178 0.7941049
Level: Sample
lower est. upper
sd((Intercept)) 0.1595688 0.2793512 0.4890497
Within-group standard error:
lower est. upper
sd((Intercept)) 0.08837785 0.12387508 0.17362988
A subject-based analysis ignores the differences in precision of estimation of means
between subjects.
> UB.LNsize.means <- tapply(Unbalanced.LymphNode$LNsize,
list(Unbalanced.LymphNode$Subject), mean, na.rm = TRUE)
> umod.lm <- lm(UB.LNsize.means ~ RT.means)
> cbind(coef(umod.lm), confint(umod.lm))
2.5% 97.5%
(Intercept) 2.3557222 1.9018505 2.8095940
RT.meansRTShort -0.1990222 -0.8722228 0.4741784
The second dataset considered here is grouped binary data from the lymph node count
example; NA indicates a missing value. For model fitting the non-missing data can be found
using the subset and complete.cases functions.
> LN.ind <- c(4, 3, 2, 2, 3, 2, 1, 1, 1, 2, 4, 3,
4, 4, 3, 4, 4, 5, 0, 2, 0, 1, 2, 4,
NA, 5, 3, 1, 4, 5, 0, NA, 1, 4, 4, 3,
NA, 2, 2, 2, 3, 3, 0, NA, 0, 0, 3, NA,
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NA, NA, NA, 1, 5, 3, 0, NA, 2, 2, 3, NA)
> Subject <- factor(rep(1:12, times = 5), levels = 1:12)
> Sample <- factor(rep(1:5, each = 12), levels = 1:5)
> nRoI <- rep(5, 60)
> RadioTherapy <- factor(rep(rep(1:2, each = 6),times=5), levels = 1:2,
labels = c("None", "RTShort"))
> nRoI <- rep(5, 60)
> gLymphNode < data.frame(Subject, Sample, RadioTherapy,
gLNind = as.numeric(LN.ind) / 5, nRoI)
> gLymphNode <- subset(gLymphNode, complete.cases(gLymphNode))
Fitting a conventional logistic regression model to the data provides a naive analysis, with
estimated coefficients that are log odds-ratios. The glm command indicates that a generalized
linear model is fitted, with distributional properties identified using the family argument, which
for binary data is canonically the binomial distribution with logit link function.
> log.reg <- glm(gLNind ~ RadioTherapy, data = gLymphNodeInd,
family = binomial("logit"), weight = nRoI)
> anova(log.reg, test = "Chisq")
Analysis of Deviance Table
Model: binomial, link: logit
Response: gLNind
Terms added sequentially (first to last)
Df Deviance Resid. Df Resid. Dev Pr(>Chi)
NULL 49 113.299
RadioTherapy 1 21.046 48 92.253 4.485e-06***
---------
Signif. codes: 0 ’***’ 0.001 ’**’ 0.01 ’*’ 0.05 ’.’ 0.1 ’ ’ 1
> cbind(exp(coef(log.reg)), exp(confint(log.reg)))
Waiting for profiling to be done...
2.5% 97.5%
(Intercept) 1.7173913 1.1997511 2.4872605
RadioTherapyRTShort 0.3053412 0.1805858 0.5096359
Fitting linear mixed-effects models for non-normal data requires the lme4 package. Model
set-up and syntax for lme4 is similar to nlme; for details of implementation for lme4 see
(Bates et al., 2015) and the vignettes provided with the package.
> install.packages("lme4")
> library(lme4)
> gmod.lme4 <- glmer(gLNind ~ RadioTherapy + (1 | Subject), data = gLymphNo-
deInd, family = binomial("logit"), weight = nRoI)
> mod.sum <- summary(gmod.lme4)
> mod.sum[["coefficients"]]["RadioTherapyRTShort","Pr(>|z|)"]
0.01592349
> par.CI <- confint(gmod.lme4, method = "Wald")
> cbind(exp(fixef(gmod.lme4)), exp(par.CI[2:3,]))
2.5% 97.5%
(Intercept) 1.8822378 0.87036620 4.0704923
RadioTherapyRTShort 0.2569425 0.08511571 0.7756438
Predictions for the fitted model can be obtained for new data using the predict function,
here with no random effects included.
> predict(gmod.lme4, newdata = data.frame(RadioTherapy = c("None",
"RTShort"), type = "response", re.form = ~ 0)
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1 2
0.3259761 0.6530474
The standard errors of the radiotherapy effects for the conventional logistic regression and
mixed-effects model are obtained from the variance-covariance matrices of the fitted model
parameters using the vcov function.
> sqrt(vcov(log.reg)["RadioTherapyRTShort", "RadioTherapyRTShort"])
0.2642883
> sqrt(vcov(gmod.lme4)["RadioTherapyRTShort", "RadioTherapyRTShort"])
0.5637047
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Appendix 4
DOI: https://doi.org/10.7554/eLife.32486.012
Mathematical description of the naive analysis
The standard method of analysis for simple designed experiments is analysis of variance
(ANOVA), which uses variability about mean values to assess significance, under an assumed
approximate Normal distribution. Focussing on samples as experimental units, it is decided to
collect m replicate measurements of an outcome y on each of T  N samples, divided into T
equally sized treatment groups. Indexing outcomes as yijt, where i ¼ 1; . . . ;N, j ¼ 1; . . . ;m and
t ¼ 1; . . . ; T, the total sums-of-squares (deviations around the mean) which sumarises overall
data variability is
SSTotal ¼
X
i
X
j
X
t
ðyijt  y:::Þ
2
where the overall (grand) mean is y::: ¼
1
TNm
P
i
P
j
P
t yijt. The Treatment sums-of-squares (SS) is
that part of the variation due to the interventions and is given by
SSTreat ¼mN
X
t
ðy::t  y:::Þ
2
where the treatment means are given by y::t ¼
1
Nm
P
i
P
j yijt. The residual or error SS is given by
SSError ¼
X
i
X
j
X
t
y2ijt  mN
X
t
y2::t
and is such that SSTotal ¼ SSTreat þ SSError. This error SS can be partitioned into that between
samples
SSError:Samples ¼m
X
i
X
t
y2i:t mN
X
t
y2::t
and that within samples
SSError:Within ¼
X
i
X
j
X
t
y2ijt m
X
i
X
t
y2i:t
where the sample means are given by yi:t ¼
1
m
P
j yijt and SSError ¼ SSError:Samples þ SSError:Within. In a
naive analysis, ignoring the sampling structure, significance between treatments is incorrectly
assessed using an F-test of the ratio of the treatment mean-square MSTreat ¼ SSTreat=ðT   1Þ to
the error mean-square MSError ¼ SSError=TðNm  1Þ on T   1 and TðNm  1Þ degrees of
freedom. However, the correct analysis is that which uses an F-test of the ratio of the
treatment mean-square MSTreat to the between samples error mean-square MSError:Samples ¼
SSError:Samples=TðN   1Þ on T   1 and TðN   1Þ degrees of freedom.
This analysis uses the variability between samples only to assess the significance of the
treatment effects. The naive analysis pools variability between and within samples and uses
this to assess the treatment effects. The naive analysis is generally the default analysis
obtained in the majority of statistics software, such as R, if the error structure is not specifically
stated in the call to analysis of variance.
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